These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 14963146

  • 1. Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.
    Payne SL, Pei XF, Jia B, Fagerness A, Fuller FJ.
    J Virol; 2004 Mar; 78(5):2478-85. PubMed ID: 14963146
    [Abstract] [Full Text] [Related]

  • 2. Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.
    Zhou T, Yuan XF, Hou SH, Tu YB, Peng JM, Wen JX, Qiu HJ, Wu DL, Chen HC, Wang XJ, Tong GZ.
    Virus Res; 2007 Sep; 128(1-2):58-64. PubMed ID: 17499380
    [Abstract] [Full Text] [Related]

  • 3. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.
    Maury W, Thompson RJ, Jones Q, Bradley S, Denke T, Baccam P, Smazik M, Oaks JL.
    J Virol; 2005 May; 79(9):5653-64. PubMed ID: 15827180
    [Abstract] [Full Text] [Related]

  • 4. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
    Lichtenstein DL, Craigo JK, Leroux C, Rushlow KE, Cook RF, Cook SJ, Issel CJ, Montelaro RC.
    Virology; 1999 Oct 25; 263(2):408-17. PubMed ID: 10544113
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus.
    Cook RF, Leroux C, Cook SJ, Berger SL, Lichtenstein DL, Ghabrial NN, Montelaro RC, Issel CJ.
    J Virol; 1998 Feb 25; 72(2):1383-93. PubMed ID: 9445039
    [Abstract] [Full Text] [Related]

  • 7. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
    Zheng YH, Sentsui H, Sugita M, Nakaya T, Kishi M, Hagiwara K, Inoshima Y, Ishihara C, Kono Y, Lu JL, Ikuta K.
    Virology; 2000 Jan 05; 266(1):129-39. PubMed ID: 10612667
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.
    Mealey RH, Leib SR, Pownder SL, McGuire TC.
    J Virol; 2004 Sep 05; 78(17):9295-305. PubMed ID: 15308724
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.
    Lichtenstein DL, Issel CJ, Montelaro RC.
    J Virol; 1996 Jun 05; 70(6):3346-54. PubMed ID: 8648664
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.